Virt-Nate Prenatal/Postnatal, Prescription Folate-Containing Dietary Supplement, Rx, 100 count bottles, Manufactured For: Virtus Pharmaceuticals, Tampa, FL
Check against the official notice below — it lists the full affected range.
Virtus Pharmaceuticals is recalling Virt-Nate Prenatal/Postnatal, a prescription folate-containing dietary supplement, because some bottles may contain tablets with incorrect imprinting. Specifically, affected bottles could contain tablets debossed with V259 (the imprint for a different product called PreTab) instead of the correct V264 imprint for Virt-Nate. The recall involves 1,139 bottles distributed in Michigan across two lot codes: Lot M143810A and Lot M143810, both expiring in July 2017.
The recall affects bottles with specific product identifiers: NDC 69543-264-10 or NDC 76439-264-10. The source document does not specify what action affected consumers should take in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
Tablets/Capsules Imprinted with Wrong ID; product debossed with an incorrect punch. Bottles could contain tablets debossed with V259 (debossing for PreTab) instead of the correct punch, V264 (debossing for Virt-Nate).
Reason for recall: Tablets/Capsules Imprinted with Wrong ID; product debossed with an incorrect punch. Bottles could contain tablets debossed with V259 (debossing for PreTab) instead of the correct punch, V264 (debossing for Virt-Nate). Distribution: MI Quantity: 1,139 bottles total Lot/code info: Lot code M143810A, exp 7/2017, NDC 69543-264-10, UPC 369543264105, and Lot code M143810, exp 7/2017, NDC 76439-264-10, UPC 376439264109
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.